Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced that it has scored $84 million in Series C funding, led by Norwest Venture Partners, with participation from other investors.
WHAT IT DOES
Cytovale offers its diagnostic test, IntelliSep, which received FDA 510(k) clearance last year. The test aims to assist in the early detection of...
South Korea clears AITRICS' AI software for predicting patient deterioration
AI startup AITRICS has obtained clearance from South Korea's Ministry of Food and Drug Safety for its AI monitoring solution.
The South Korean startup has developed VitalCare, an AI software for predicting a patient's risk of cardiac arrest, sepsis and death within 4-6 hours in the ICU. It tracks six vital parameters, 11...
TIIM Healthcare, an AI health technology company in Singapore, has received an exclusive IP license to commercialise a novel technology developed by the Duke-NUS Medical School to identify patients at risk of dying from sepsis.
Established in 2016, TIIM, which stands for Technology Innovation in Medicine, develops AI triaging solutions. Its flagship product, aiTRIAGE, incorporates both heart rate...
What happened
Researchers at a university in Scotland have developed a test that they say could save thousands of lives by diagnosing sepsis in two and a half minutes, faster than existing methods, according to a new study published in the Biosensors and Bioelectronics journal.
It uses a biosensor device to test for interleukin-6 (IL-6), one of the protein biomarkers of sepsis, in the blood.
“We...
Ambient Clinical Analytics, a remote patient monitoring company that spun off from Mayo Clinic in 2013, has raised $1.5 million in a round led by Noaber Ventures, the impact investment arm of Noaber Foundation and the company’s first European investor. Existing investors Social Capital, Bluestem Capital, and Mayo Clinic also contributed to the round.
“The company is making great progress, and...
